Women with polycystic ovary syndrome (PCOS) are at increased risk of develo
ping diabetes mellitus type 2, Insulin resistance plays a key role in the p
redisposition to diabetes in PCOS; however, defects in insulin secretion al
so appear to contribute to its development. Since diabetes mellitus is not
a universal consequence in PCOS, however, it is important to develop means
to identify those women who are at highest risk. In this way, it may become
possible to delay or even prevent the onset of diabetes mellitus in later
life. Identification of genetic factors and use of pharmacological agents m
ay allow early identification of those women with PCOS who are at greatest
risk for development of diabetes mellitus type 2.